Drug Approvals - B
Product Name Company Application # Approval Date Letter Posted Label Posted Review Posted Bacitracin Injection, 50,000 units/vial, Rx American Pharmaceutical Partners ANDA 65-116 12/3/02 - - - Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP, Rx Altana, Inc NDA 21-286/S2 2/12/03 2/25/03 - - Benicar (olmesartan medoxomil) Tablets, 5, 20, and 40 mg, Rx Sankyo Pharma,...
http://www.fda.gov/cder/orange/appendix_a.txt
3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
Drug Approval Package
Food and Drug Administration Center for Drug Evaluation and Research Approval Package Search Blocadren (Timolol Maleate) Tablets Company:--Merck & Co Application No.:--18-017/S36 Approval Date:-2/25/03 Approval Letter(s) - Medical Review(s) - Clinical Pharmacology Biopharmaceutics Review(s) - Administrative Document(s) - - Back to Drug Approval Page Some...
author: USERNAME
C:\Data\N20330S17AP.doc
NDA 20- 330/ S- 017 Page 3 STERILE OPHTHALMIC GEL FORMING SOLUTION TIMOPTIC- XE® 0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION) DESCRIPTION TIMOPTIC- XE (timolol maleate ophthalmic gel forming solution) is a non- selective beta- adrenergic receptor blocking agent Each mL of TIMOPTIC- XE 0.5% contains 5 mg of timolol (6.8 mg of ...
author: Michael Puglisi
C:\Data\N19463S26AP.doc
NDA 19- 463/ S- 026 Page 3 PRESERVATIVE- FREE STERILE OPHTHALMIC SOLUTION in a Sterile Ophthalmic Unit Dose Dispenser TIMOPTIC® 0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC SOLUTION) in OCUDOSE® (DISPENSER) DESCRIPTION Timolol maleate is a non- selective beta- adrenergic receptor blocking agentTimolol maleate ophthalmic solution is supplied in two...
author: Michael Puglisi
C:\Data\N18086S60AP.doc
NDA 18- 086/ S- 060 Page 3 STERILE OPHTHALMIC SOLUTION TIMOPTIC® 0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC SOLUTION) DESCRIPTION TIMOPTIC (timolol maleate ophthalmic solution) is a non- selective beta- adrenergic receptor blocking agent TIMOPTIC Ophthalmic Solution is supplied as a sterile, isotonic, buffered, aqueous solution of timolol maleate in...
author: Michael Puglisi
http://www.merck.com/product/usa/pi_circulars/t/timolide/timolide_pi.pdf page 10
duplicates:http://www.merck.com/product/usa/pi_circulars/t/timolide/timolide_pi.pdf
http://www.merck.com/product/usa/pi_circulars/t/timolide/timolide_pi.pdf
7928435 1 TABLETS TIMOLIDE ® (TIMOLOL MALEATE- HYDROCHLOROTHIAZIDE) DESCRIPTION TIMOLIDE * (Timolol Maleate- Hydrochlorothiazide) is for the treatment of hypertension Plasma volume may decrease or remain unchanged during therapy with timolol maleate If cardiac failure persists, therapy with TIMOLIDE should be withdrawn Thiazides may decrease serum PBI levels without...
duplicates:http://www.merck.com/product/usa/pi_circulars/t/timolide/timolide_pi.pdf
FDA Drug Approvals List March 2002
- Drug Approvals for March 2002 Definitions and Notes Original New Drug Applications Original Application #: 020855 Approval Date: 21-MAR-02 Trade Name: MESNA Chemical Type: 3 Therapeutic Potential: S Dosage Form: TABLET Applicant: ASTA MEDICA AG Active Ingredient(s): MESNA OTC/RX Status: RX Indication(s): For the use as a prophylactic agent in reducing the incidence of ifosfamide...
TIMPILO Product Monograph
Potential Side Effects Side effects reported in clinical and post- marketing experience with TIMOPTIC ® (timolol maleate ophthalmic solution, Merck Frosst Std.), systemic BLOCADREN ® (timolol maleate tablets, Merck Frosst Std.), other timolol maleate formulations and pilocarpine ophthalmic solution may be considered potential side effects of TIMPILO ...
author: Merck Frosst Canada & Co.
subject: 644-a,5,00
TIMPILO Product Monograph page 4
author: Merck Frosst Canada & Co.
subject: 644-a,5,00
http://www.merck.com/product/usa/pi_circulars/t/timoptic/timoptic_xe_pi.pdf
9028714 1 STERILE OPHTHALMIC GEL FORMING SOLUTION TIMOPTIC- XE ® 0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION) DESCRIPTION TIMOPTIC- XE * (timolol maleate ophthalmic gel forming solution) is a non- selective betaadrenergic receptor blocking agent TIMOPTIC- XE ® 9028714 (timolol maleate ophthalmic gel forming solution) 8 The...
http://www.merck.com/product/usa/pi_circulars/t/timoptic/timoptic_optsol_pi.pdf
9391001 1 STERILE OPHTHALMIC SOLUTION TIMOPTIC ® 0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC SOLUTION) DESCRIPTION TIMOPTIC * (timolol maleate ophthalmic solution) is a non- selective beta- adrenergic receptor blocking agent Overdosage has been reported with Tablets BLOCADREN * (timolol maleate tablets) A 30 year old female ingested 650 mg of ...
http://www.merck.com/product/usa/pi_circulars/t/timoptic/timoptic_ocudose_pi.pdf
9351204 1 PRESERVATIVE- FREE STERILE OPHTHALMIC SOLUTION in a Sterile Ophthalmic Unit Dose Dispenser TIMOPTIC ® 0.25% AND 0.5% (TIMOLOL MALEATE OPHTHALMIC SOLUTION) in OCUDOSE ® (DISPENSER) DESCRIPTION Timolol maleate is a non- selective beta- adrenergic receptor blocking agent TIMOPTIC (timolol maleate ophthalmic solution), when applied topically on the eye, has the...
duplicates:http://www.merck.com/product/usa/pi_circulars/t/timoptic/timoptic_ocudose_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
7901233 1 TABLETS BLOCADREN ® (TIMOLOL MALEATE) DESCRIPTION BLOCADREN * (Timolol Maleate) is a non- selective beta- adrenergic receptor blocking agent In most patients the antihypertensive activity of BLOCADREN is maintained with long- term therapy and is well tolerated The level of beta sympathetic activity varies widely among individuals, and no simple correlation exists...
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf page 10
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf page 9
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf page 8
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf page 7
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf page 6
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf page 5
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf page 4
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf page 3
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf page 2
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf
http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf page 1
duplicates:http://www.merck.com/product/usa/pi_circulars/b/blocadren/blocadren_pi.pdf